J
Jayant Sastri Goda
Researcher at Homi Bhabha National Institute
Publications - 83
Citations - 1051
Jayant Sastri Goda is an academic researcher from Homi Bhabha National Institute. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 13, co-authored 53 publications receiving 718 citations. Previous affiliations of Jayant Sastri Goda include Post Graduate Institute of Medical Education and Research & University of Toronto.
Papers
More filters
Journal ArticleDOI
Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapy
Jayant Sastri Goda,Mary Gospodarowicz,Melania Pintilie,Woodrow Wells,David C. Hodgson,Alexander Sun,Micheal Crump,Richard W. Tsang +7 more
TL;DR: This study was conducted to evaluate the long‐term outcomes in patients with stage IE and IIE mucosa‐associated lymphoid tissue (MALT) lymphomas treated with involved field radiotherapy (RT).
Journal ArticleDOI
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
Richard W. Tsang,Belinda A. Campbell,Jayant Sastri Goda,Chris R. Kelsey,Youlia M. Kirova,Rahul R. Parikh,Andrea K. Ng,Umberto Ricardi,Chang Ok Suh,Peter Mauch,Lena Specht,Joachim Yahalom +11 more
TL;DR: This guideline reviews the diagnostic work-up, principles, and indications for RT, target volume definition, treatment planning, and follow-up procedures for solitary plasmacytoma, and presents a standardized approach to the use and implementation of definitive RT in solitaryPlasma cell neoplasms.
Journal ArticleDOI
Localized Orbital Mucosa-Associated Lymphoma Tissue Lymphoma Managed With Primary Radiation Therapy: Efficacy and Toxicity
Jayant Sastri Goda,Lisa W. Le,Normand J. Lapperriere,Barbara-Ann Millar,David Payne,Mary Gospodarowicz,Woodrow Wells,David C. Hodgson,Alexander Sun,Rand Simpson,Richard W. Tsang +10 more
TL;DR: POML responds favorably to moderate doses of RT but results in significant late morbidity, andLens shielding reduced the risk of cataracts and other late sequelae.
Journal ArticleDOI
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
Andrea K. Ng,Joachim Yahalom,Jayant Sastri Goda,Louis S. Constine,Chelsea C. Pinnix,Chris R. Kelsey,Bradford S. Hoppe,Masahiko Oguchi,Chang Ok Suh,Andrew Wirth,Shunan Qi,Andrew Davies,Craig H. Moskowitz,Siddhartha Laskar,Yexiong Li,Peter Mauch,Lena Specht,Timothy M Illidge +17 more
TL;DR: The rationale for considering radiation therapy (RT) for selected patients with relapsed/refractory DLBCL as a part of the salvage program is based on data regarding the patterns of relapse and retrospective series showing improved local control and clinical outcomes for patients who received peritransplant RT.
Journal ArticleDOI
Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence.
Ekjot Kaur,Jacinth Rajendra,Shailesh Jadhav,Epari Shridhar,Jayant Sastri Goda,Aliasgar Moiyadi,Shilpee Dutt +6 more
TL;DR: This is the first report showing radiation-induced homotypic cell fusions as novel non-genetic mechanism in radiation-resistant cells to sustain survival, and underscores the importance of non-proliferative phase in resistant glioma cells.